Search Results 9411-9420 of 33214 for oral

1. A Study to Evaluate AFPᶜ³³²T in Advanced HCC - Mayo Clinic

   Effective contraceptive methods include intra-uterine device, oral and injectable hormonal contraception, or 2 adequate barrier methods (e.g., diaphragm ...

2. A Study of Entrectinib (RXDX-101) for the Treatment of Patients with Solid Tumors that have NTRK1/2/3, ROS1, or ALK Gene Rearrangements - Mayo Clinic

   Progestogen-only oral hormonal contraception not having inhibition of ovulation as the primary mode of action, condoms, diaphragms, caps (with spermicide) ...

3. Single-Ascending Dose Study of JK07 in Subjects With HFpEF - Mayo Clinic

   requiring home oxygen, chronic nebulizer therapy, chronic oral steroid therapy or hospitalized for pulmonary decompensation within 12 months of informed ...

4. Head and Neck Cancer Center - Doctors - Mayo Clinic

   ... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...

5. Medical Research & Education - Mayo Clinic News Network

   Prior Oral Contraceptive Use Associated with Better Outcome for Ovarian Cancer Patients. Joe Dangor. November 11, 2015. Cardiovascular. Genetic Risk Information ...

6. Electrophysiological Comparison of mAP and mADM Using EMG - Mayo Clinic

   Patients on oral anticholinesterase, anti-seizure medications, and magnesium sulfate. Participating Mayo Clinic locations. Study statuses change often ...

7. Publications - Sherif A. El Nashar, M.B., B.Ch., M.S. - Mayo Clinic

   ... oral board examinees in different practice settings. Int Urogynecol J. 2019 Jul; 30 (7):1153-1161 Epub 2018 Apr 13. View PubMed; Hassani DB, Mangel JM ...

8. A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma - Mayo Clinic

   Is unable to take oral medications, or has malabsorption syndrome or any other uncontrolled gastrointestinal condition (e.g., nausea, diarrhea or vomiting) ...

9. A Study to Evaluate Tazemetostat Combined with Lenalidomide Plus Rituximab in Subjects With Relapsed/Refractory Follicular Lymphoma - Mayo Clinic

   Are unable to take oral medication OR have malabsorption syndrome or any other uncontrolled gastrointestinal condition (eg, nausea, diarrhea, vomiting) that ...

10. Study to Investigate CSL112 in Subjects With Acute Coronary Syndrome - Mayo Clinic

    Injectable single hormone, oral hormonal contraceptive (e.g., combined or progesterone only), contraceptive medication patch, or estrogen/progestin vaginal ...